Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICH Control Group Guidance Fails To Harmonize Requirements - AstraZeneca

Executive Summary

The International Conference on Harmonization's clinical trial control groups guidance should offer more specific advice on how to select a control group acceptable to all ICH regulators, AstraZeneca said in recent comments to FDA.

You may also be interested in...



Past FDA Action Is Not Necessarily Predictive Of Future Behavior – Temple

Sponsors should not assume clinical trials are immune from evaluation according to updated efficacy standards, even if parameters are initially agreed upon with the agency

Past FDA Action Is Not Necessarily Predictive Of Future Behavior – Temple

Sponsors should not assume clinical trials are immune from evaluation according to updated efficacy standards, even if parameters are initially agreed upon with the agency

ICH Suggests Antihypertensive Drug Trials Add Focus On Systolic Measures

Clinical trials for new antihypertensive drugs need an increased focus on systolic blood pressure reduction, an International Conference on Harmonization draft guidance on antihypertensive drug development states.

UsernamePublicRestriction

Register

OM016276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel